ADC Therapeutics (ADCT) Total Debt (2020 - 2026)
ADC Therapeutics (ADCT) posted Total Debt of $115.7 million for Q1 2026, little changed sequentially from $115.5 million in Q4 2025, and up 1.63% YoY from $113.8 million in Q1 2025.
ADC Therapeutics (ADCT) Total Debt (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Total Debt for 7 years, with the latest figure at $115.7 million in Q1 2026.
- Quarterly Total Debt rose 1.63% year-over-year to $115.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.7 million (up 1.63% YoY) and the FY2025 annual result came in at $115.5 million, up 1.6% from the prior year.
- Total Debt was little changed at $115.7 million in Q1 2026 per ADCT's latest filing, from $115.5 million in the prior quarter.
- Over five years, Total Debt peaked at $122.2 million in Q4 2022 and troughed at $95.0 million in Q1 2022.
- A 5-year average of $111.7 million and a median of $113.6 million in 2024 frame the typical range for Total Debt.
- The sharpest annual moves came in 2022 and 2023: Total Debt jumped 141.23% in 2022, then retreated 7.74% in 2023.
- Over 5 years, Total Debt stood at $122.2 million in 2022, then dropped by 7.74% to $112.7 million in 2023, then increased by 0.8% to $113.6 million in 2024, then increased by 1.6% to $115.5 million in 2025, then gained by 0.19% to $115.7 million in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $115.7 million, $115.5 million, and $115.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | 116.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 116.64 Mn |
| Mar 31, 2026 | 115.68 Mn |
| Dec 31, 2025 | 115.45 Mn |
| Sep 30, 2025 | 115.21 Mn |
| Jun 30, 2025 | 114.50 Mn |
| Mar 31, 2025 | 113.82 Mn |
| Dec 31, 2024 | 113.63 Mn |
| Sep 30, 2024 | 114.20 Mn |
| Jun 30, 2024 | 113.70 Mn |
| Mar 31, 2024 | 113.23 Mn |
| Dec 31, 2023 | 112.73 Mn |
| Sep 30, 2023 | 112.04 Mn |
| Jun 30, 2023 | 111.30 Mn |
| Mar 31, 2023 | 110.54 Mn |
| Dec 31, 2022 | 122.19 Mn |
| Sep 30, 2022 | 109.23 Mn |
| Jun 30, 2022 | 96.42 Mn |
| Mar 31, 2022 | 94.96 Mn |
| Dec 31, 2021 | 93.73 Mn |
| Sep 30, 2021 | 92.45 Mn |